TABLE 5.
Screening Rates During and After Enrollment Into the Program Evaluation
PHQ-2 Screening,a % | Complete PHQ-9 Screening,b % | |
---|---|---|
Program enrollment period (Apr. 2017–Nov. 2018) | 91.8 | 90.5 |
Brief follow-up period (Feb. 2019–May 2019) | 25.1 | 58.8 |
Abbreviations: PHQ-2, Patient Health Questionnaire-2; PHQ-9, Patient Health Questionnaire-9.
a Among all new antiretroviral therapy initiators.
b Among those who endorse the PHQ-2.